LLY

1,005.35

-1.92%↓

JNJ

246.09

-0.44%↓

ABBV

233.53

+0.32%↑

NVS

163.18

-2.06%↓

MRK

120.37

-0.97%↓

LLY

1,005.35

-1.92%↓

JNJ

246.09

-0.44%↓

ABBV

233.53

+0.32%↑

NVS

163.18

-2.06%↓

MRK

120.37

-0.97%↓

LLY

1,005.35

-1.92%↓

JNJ

246.09

-0.44%↓

ABBV

233.53

+0.32%↑

NVS

163.18

-2.06%↓

MRK

120.37

-0.97%↓

LLY

1,005.35

-1.92%↓

JNJ

246.09

-0.44%↓

ABBV

233.53

+0.32%↑

NVS

163.18

-2.06%↓

MRK

120.37

-0.97%↓

LLY

1,005.35

-1.92%↓

JNJ

246.09

-0.44%↓

ABBV

233.53

+0.32%↑

NVS

163.18

-2.06%↓

MRK

120.37

-0.97%↓

Kodu・Aktsiate loetelu・Avalo Therapeutics

A
Avalo Therapeutics

Avatud

16.93 -0.99

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

16.93

Max

17.96

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+124.69% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	19. märts 2026

Avalo Therapeutics Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. märts 2026, 23:41 UTC

Market Talk

Uudisväärsed sündmused

Nikkei May Decline on Concerns About Energy Prices -- Market Talk

2. märts 2026, 23:37 UTC

Market Talk

Uudisväärsed sündmused

Gold Edges Higher Amid Middle East Conflict -- Market Talk

2. märts 2026, 23:26 UTC

Uudisväärsed sündmused

How the Iran Conflict Could Pressure Consumer Staples Companies -- Barrons.com

2. märts 2026, 22:41 UTC

Market Talk

Australian Reits Wait on Recovery in Trading Multiples -- Market Talk

2. märts 2026, 22:32 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2. märts 2026, 22:32 UTC

Market Talk

RBA Cautious About Potential for Energy Supply Shocks -- Market Talk

2. märts 2026, 22:21 UTC

Market Talk

Port of Tauranga's Upgraded Profit View Still Looks Conservative -- Market Talk

2. märts 2026, 22:11 UTC

Market Talk

Global Equities Roundup: Market Talk

2. märts 2026, 22:11 UTC

Market Talk

Don't Lose Sight of Bigger Picture With Summerset -- Market Talk

2. märts 2026, 22:10 UTC

Omandamised, ülevõtmised, äriostud

IAC Is Near Deal to Sell Care.com to Private-Equity Firm -- WSJ

2. märts 2026, 22:06 UTC

Market Talk

Channel Infrastructure's Dividend Positively Surprises -- Market Talk

2. märts 2026, 22:00 UTC

Market Talk

Tulu

Global Forex and Fixed Income Roundup: Market Talk

2. märts 2026, 22:00 UTC

Market Talk

Tulu

Fashion Retailer Hallenstein Glasson Still a Smart Buy -- Market Talk

2. märts 2026, 21:50 UTC

Market Talk

Uudisväärsed sündmused

Energy & Utilities Roundup: Market Talk

2. märts 2026, 21:50 UTC

Market Talk

Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

2. märts 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

2. märts 2026, 21:35 UTC

Omandamised, ülevõtmised, äriostud

AT&T Expects Net Debt-To-Adjusted Ebitda Ratio Will Rise to About 3.2x Following Deal With EchoStar and Decline to About 3x by End of 2026

2. märts 2026, 21:34 UTC

Omandamised, ülevõtmised, äriostud

AT&T Remains on Track to Achieve Its 2026 and Multi-Yr Fincl Guidance

2. märts 2026, 21:30 UTC

Omandamised, ülevõtmised, äriostud

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2. märts 2026, 21:17 UTC

Uudisväärsed sündmused

Bank, Brokerage Stocks Recover Lost Ground After Last Week's Selloff -- Despite Iran Conflict -- Barrons.com

2. märts 2026, 20:44 UTC

Tulu

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2. märts 2026, 20:43 UTC

Market Talk

Uudisväärsed sündmused

Treasury Yields Rise, Dollar Strengthens After Attack on Iran -- Market Talk

2. märts 2026, 20:28 UTC

Tulu

Strategy Stock Rises. The World's Largest Bitcoin Holder Doubles Down on Its Crypto Bet. -- Barrons.com

2. märts 2026, 20:25 UTC

Market Talk

Uudisväärsed sündmused

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

2. märts 2026, 20:24 UTC

Tulu

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2. märts 2026, 20:14 UTC

Omandamised, ülevõtmised, äriostud

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2. märts 2026, 20:12 UTC

Uudisväärsed sündmused

Palantir Rises on Mideast Conflict. Why It's Moving Like a Defense Stock. -- Barrons.com

2. märts 2026, 20:08 UTC

Market Talk

Uudisväärsed sündmused

Global Forex and Fixed Income Roundup: Market Talk

2. märts 2026, 20:08 UTC

Market Talk

Uudisväärsed sündmused

Higher Oil Prices Could Boost Capex in Canada Energy Patch -- Market Talk

2. märts 2026, 20:05 UTC

Market Talk

Uudisväärsed sündmused

Oil Rises On U.S.-Middle East Conflict, But Settles Off Highs -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Avalo Therapeutics Prognoos

Hinnasiht

By TipRanks

124.69% tõus

12 kuu keskmine prognoos

Keskmine 40.4 USD 124.69%

Kõrge 50 USD

Madal 25 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Avalo Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

5 ratings

Osta

Hoia

Müü

Põhineb 5 analüütiku instrumendi Avalo Therapeutics aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

1,005.35

↓-1.92%

JNJ

Johnson and Johnson

246.09

↓-0.44%

ABBV

AbbVie Inc

233.53

↑ +0.32%

NVS

Novartis AG

163.18

↓-2.06%

MRK

Merck & Co Inc.

120.37

↓-0.97%

A Avalo Therapeutics

Ülevaade

Aktsiahinna muutus

Soovitused

Dividendid

Avalo Therapeutics Graafik

Seotud uudised

Võrdlus sarnastega

Avalo Therapeutics Prognoos

Hinnasiht

Hinnangu Konsensus

Finantsandmed

Muud aktsiad sektorist

A
Avalo Therapeutics